Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Brainstorm Cell Theraputc (BCLI)

Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine PR Newswire - Tue Jun 2, 8:00AM CDT

Former FDA Associate Commissioner Peter Pitts and BrainStorm's Chaim Lebovits argue that regulation must keep pace with advances in biomarkers, AI, cell therapy and precision medicine

BCLI : 0.8645 (+1.71%)
BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors PR Newswire - Thu May 28, 6:45AM CDT

Former Senior FDA Official Joins Board as Company Prepares to Initiate Historic Phase 3b ALS Trial Under Special Protocol Assessment

BCLI : 0.8645 (+1.71%)
BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market PR Newswire - Tue May 19, 7:00AM CDT

$2.4 Million in H1 2026 Capital Raises Ahead of Phase 3b ENDURANCE Trial

BCLI : 0.8645 (+1.71%)
BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update PR Newswire - Fri May 15, 3:05PM CDT

NEW YORK , May 15, 2026 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial...

BCLI : 0.8645 (+1.71%)
BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update PR Newswire - Tue Mar 31, 3:01PM CDT

Strategic $2.0 million post year-end financing and re-rating of BCLI shares underscore market confidence

BCLI : 0.8645 (+1.71%)
Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February PR Newswire - Thu Feb 26, 5:22AM CST

NEW YORK , Feb. 26, 2026 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced it has...

BCLI : 0.8645 (+1.71%)
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market PR Newswire - Fri Feb 20, 5:00AM CST

NEW YORK , Feb. 20, 2026 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced it has...

BCLI : 0.8645 (+1.71%)
BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update PR Newswire - Fri Nov 14, 2025

NEW YORK , Nov. 14, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial...

BCLI : 0.8645 (+1.71%)
Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights Business Wire - Mon Oct 27, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

BCLI : 0.8645 (+1.71%)
Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights Business Wire - Mon Oct 27, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

BCLI : 0.8645 (+1.71%)

Barchart Exclusives

Dear MicroStrategy Stock Fans, Mark Your Calendars for July 4 Barchart - Sat Jun 20, 11:00AM CDT
Strategy investors are closely watching the July 4 CLARITY Act deadline, which could reshape crypto regulation and influence bitcoin-linked stocks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.